300 related articles for article (PubMed ID: 21492259)
21. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
22. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
Quan L; Morita R; Kawakami S
Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
[TBL] [Abstract][Full Text] [Related]
23. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
24. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
25. Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes.
Zhao YX; Abdelnour A; Ljungdahl A; Olsson T; Tarkowski A
Cell Immunol; 1995 Mar; 161(1):28-33. PubMed ID: 7867082
[TBL] [Abstract][Full Text] [Related]
26. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
Fukushima H; Hirano T; Oka K
Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
[TBL] [Abstract][Full Text] [Related]
28. The toxic shock syndrome toxin-1 induces anergy in human T cells in vivo.
Mahlknecht U; Herter M; Hoffmann MK; Niethammer D; Dannecker GE
Hum Immunol; 1996 Jan; 45(1):42-5. PubMed ID: 8655359
[TBL] [Abstract][Full Text] [Related]
29. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
30. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen.
Takahashi N; Imanishi K; Nishida H; Uchiyama T
J Immunol; 1995 Dec; 155(11):5213-9. PubMed ID: 7594532
[TBL] [Abstract][Full Text] [Related]
31. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
[TBL] [Abstract][Full Text] [Related]
32. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
33. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
34. Necrotizing fasciitis caused by TSST-1 producing penicillin-sensitive Staphylococcus aureus--a case report.
Omland LH; Rasmussen SW; Hvolris J; Friis-Møller A
Acta Orthop; 2007 Apr; 78(2):296-7. PubMed ID: 17464622
[No Abstract] [Full Text] [Related]
35. Porcine MHC classical class I genes are coordinately expressed in superantigen-activated mononuclear cells.
Kametani Y; Ohshima S; Kita YF; Shimada S; Kamiguchi H; Shiina T; Inoko H; Kulski JK; Ando A
Vet Immunol Immunopathol; 2012 Aug; 148(3-4):252-9. PubMed ID: 22640570
[TBL] [Abstract][Full Text] [Related]
36. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen.
Takahashi N; Kato H; Imanishi K; Miwa K; Yamanami S; Nishida H; Uchiyama T
J Clin Invest; 2000 Dec; 106(11):1409-15. PubMed ID: 11104794
[TBL] [Abstract][Full Text] [Related]
37. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
38. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci.
Abdelnour A; Bremell T; Holmdahl R; Tarkowski A
Eur J Immunol; 1994 May; 24(5):1161-6. PubMed ID: 8181526
[TBL] [Abstract][Full Text] [Related]
39. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
[TBL] [Abstract][Full Text] [Related]
40. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
